AMICUS THERAPEUTICS, INC. — Director's Dealing 2016

Jan 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2016-01-04

Reporting Person: Campbell Bradley L (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-04	Common stock	M	50000	—	Acquired	56575	Direct
2016-01-04	Common stock	F	18625	$9.03	Disposed	37950	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-04	Restricted stock units	$	M	50000	Disposed		Common Stock (50000)	Direct
2016-01-04	Stock Options (right to buy)	$9.03	A	100000	Acquired	2026-01-04	Common Stock (100000)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: On April 10, 2014, the reporting person was granted 100,000 restricted stock units, vesting in equal installments of 50,000 restricted stock units on May 10, 2015 and 50,000 restricted stock units on December 3, 2015. On June 26, 2014, the reporting person was granted 100,000 restricted stock units, vesting in its entirety on July 1, 2016.

F3: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 4, 2017. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2017, with the final installment vesting on January 1, 2020.